Skip to content
香港聯合腫瘤中心
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Doctor Updates
    • Join us
  • 繁
  • En
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Doctor Updates
    • Join us
  • 繁
  • En

Category: 乳癌

藥物資訊-FDA批準Enhertu新适應症！首個HER2低表達乳腺癌靶向療法面世

The FDA approved the new indication of Enhertu! The first targeted therapy for HER2 low-expression breast cancer is available

8月5日，阿斯利康（AstraZeneca）和第一三共制藥（ Daiichi Sankyo）共同研發的乳腺癌藥物 Enhertu (fam-trast

立即閱讀
November 17, 2022 No Comments
藥物資訊-HER2基因突變型乳癌標靶治療

Targeted therapy for HER2 gene-mutant breast cancer

乳癌是本港女性健康大敵，每年超過4,100宗新症。預料個案數字隻會有增無減。近年醫藥界積極進行研究，以占乳癌個案約兩成的HER2基因突變型乳癌爲例，目

立即閱讀
November 17, 2022 No Comments
藥物資訊-第一三共在日本遞交Enhertu治療HER2低表達乳腺癌新适應症上市申請

Daiichi Sankyo submits a listing application for a new indication of Enhertu for the treatment of HER2 low-expression breast cancer in Japan

乳腺癌患者中，HER2 陽性約占 15％ – 20％，而剩餘的 HER2 陰性患者中，HER2 低表達患者占 45％ – 55

立即閱讀
November 16, 2022 No Comments
藥物資訊-HER2靶向ADC藥物Enhertu在歐盟獲批

HER2 targeted ADC drug Enhertu is approved in the European Union

2022年7月19日，阿斯利康發布聲明宣布，其與第一三共合作的HER2靶向ADC藥物Enhertu在歐盟獲得批準，作爲單一療法，用於接受一種或多種先前

立即閱讀
November 12, 2022 No Comments
藥物資訊-Trodelvy獲批用於轉移性三陰性乳腺癌的二線治療

Trodelvy is approved for the second-line treatment of metastatic triple-negative breast cancer

三陰性乳腺癌是一種高度侵襲且目前難以治療的疾病，約占全球所有乳腺癌類型的 15%。在亞洲，乳腺癌的确診年齡中位數與西方國家相比有年輕化趨勢，近10年來

立即閱讀
November 8, 2022 No Comments
藥物資訊-Enhertu已經獲得美國FDA優先審查資格

Enhertu has obtained the US FDA priority review qualification

Enhertu（DS-8201）用於治療HER2突變的不可切除或轉移性非小細胞肺癌經治患者，這一适應症已獲得美國FDA授予了優先審查資格。2022年4

立即閱讀
November 8, 2022 No Comments
藥物資訊-三陰性乳腺癌抗體偶聯藥Trodelvy最新數據

Latest data on Trodelvy, an antibody-coupled drug for triple-negative breast cancer

三陰性乳腺癌（TNBC）是一種侵襲性乳腺癌，約占所有乳腺癌的15％。該疾病在年輕和絕經前女性中的更常見。三陰性是指雌激素受體（ER）、孕激素受體（PR

立即閱讀
November 8, 2022 No Comments
基因簡介-MSI簡介

Introduction to MSI

MSI (結直腸癌，乳腺癌、子宮內膜癌、胃癌) 微衛星不穩定（MSI）是指由於在DNA複製時插入或缺失突變引起的MS序列長度改變的現象，常由錯配修復（

立即閱讀
September 2, 2022 No Comments
基因簡介-ER/PR 簡介

ER/PR Introduction

ER/PR基因陽性 (乳腺癌) 臨床上可以通過對雌激素受體（ER）和孕激素受體（PR）的檢測，得出腫瘤細胞內激素受體含量的水平，從而提示乳腺癌的預後資

立即閱讀
September 2, 2022 No Comments
基因簡介-BRCA簡介

BRCA Introduction

BRCA 突變 (乳腺癌、卵巢癌、前列腺癌，胰臟癌) BRCA基因是抑癌基因，抑癌基因可以幫助人體修復受損的DNA，避免異常細胞擴增，防止癌症的發生，

立即閱讀
September 2, 2022 No Comments
Page1 Page2 Page3 Page4 Page5
香港聯合腫瘤中心

The Hong Kong United Oncology Centre (HKUOC) provides cancer-related medical services such as cancer screening, cancer diagnosis and cancer treatment, including immunotherapy, chemotherapy, targeted drug therapy, radiation therapy, hormone therapy and palliative care.

Contact us

  • Address: Rooms 01-06, 20/F, 238 Nathan Road, Kowloon (MTR Jordan Station Exit E)
  • Phone: +852 2386 8002
  • WhatsApp：5518 2992
  • Fax: (852) 2386 8229
  • Macau: Enquiry@hkuoc.hk

Consultation time

Monday to Friday

9:00 am to 1:00 pm

2:00 p.m. to 6:00 p.m.

Saturday

9:00 am to 1:00 pm

Closed on Sundays and public holidays

Types of cancer

  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer
  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer

Cancer treatment

  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy
  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy

phone

WhatsApp

Facebook